Subcutaneous Fat Necrosis During Nivolumab Therapy for Metastatic Melanoma.
JAMA Dermatol
; 157(4): 468-469, 2021 04 01.
Article
in En
| MEDLINE
| ID: mdl-33688919
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Skin Neoplasms
/
Subcutaneous Fat
/
Antineoplastic Agents, Immunological
/
Nivolumab
/
Melanoma
Limits:
Aged
/
Female
/
Humans
Language:
En
Journal:
JAMA Dermatol
Year:
2021
Document type:
Article